Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 21767835)


Risk factors for very preterm delivery and delivery of very-small-for-gestational-age infants among HIV-exposed and HIV-unexposed infants in Botswana.

Parekh N, Ribaudo H, Souda S, Chen J, Mmalane M, Powis K, Essex M, Makhema J, Shapiro RL.

Int J Gynaecol Obstet. 2011 Oct;115(1):20-5. doi: 10.1016/j.ijgo.2011.04.008. Epub 2011 Jul 20.


Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.

Chen JY, Ribaudo HJ, Souda S, Parekh N, Ogwu A, Lockman S, Powis K, Dryden-Peterson S, Creek T, Jimbo W, Madidimalo T, Makhema J, Essex M, Shapiro RL.

J Infect Dis. 2012 Dec 1;206(11):1695-705. doi: 10.1093/infdis/jis553. Epub 2012 Oct 12.


Maternal HIV infection associated with small-for-gestational age infants but not preterm births: evidence from rural South Africa.

Ndirangu J, Newell ML, Bland RM, Thorne C.

Hum Reprod. 2012 Jun;27(6):1846-56. doi: 10.1093/humrep/des090. Epub 2012 Mar 21.


Association of HIV infection with spontaneous and iatrogenic preterm delivery: effect of HAART.

Lopez M, Figueras F, Hernandez S, Lonca M, Garcia R, Palacio M, Coll O.

AIDS. 2012 Jan 2;26(1):37-43. doi: 10.1097/QAD.0b013e32834db300.


Birth weight for gestational age norms for a large cohort of infants born to HIV-negative women in Botswana compared with norms for U.S.-born black infants.

Matthews LT, Ribaudo HJ, Parekh NK, Chen JY, Binda K, Ogwu A, Makhema J, Souda S, Lockman S, Essex M, Shapiro RL.

BMC Pediatr. 2011 Dec 16;11:115. doi: 10.1186/1471-2431-11-115.


Pregnancy outcomes and risk factors for low birth weight and preterm delivery among HIV-infected pregnant women in Guangxi, China.

Yu L, Li WY, Chen RY, Tang ZR, Pang J, Gui XZ, Meng XN, Zhang FJ.

Chin Med J (Engl). 2012 Feb;125(3):403-9.


Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth.

Szyld EG, Warley EM, Freimanis L, Gonin R, Cahn PE, Calvet GA, Duarte G, Melo VH, Read JS; NISDI Perinatal Study Group.

AIDS. 2006 Nov 28;20(18):2345-53.


Risk of preeclampsia in HIV-positive pregnant women receiving HAART: a matched cohort study.

Boyajian T, Shah PS, Murphy KE.

J Obstet Gynaecol Can. 2012 Feb;34(2):136-41.


Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study.

van der Merwe K, Hoffman R, Black V, Chersich M, Coovadia A, Rees H.

J Int AIDS Soc. 2011 Aug 15;14:42. doi: 10.1186/1758-2652-14-42.


Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.

Schulte J, Dominguez K, Sukalac T, Bohannon B, Fowler MG; Pediatric Spectrum of HIV Disease Consortium.

Pediatrics. 2007 Apr;119(4):e900-6. Epub 2007 Mar 12.


Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception.

Machado ES, Hofer CB, Costa TT, Nogueira SA, Oliveira RH, Abreu TF, Evangelista LA, Farias IF, Mercadante RT, Garcia MF, Neves RC, Costa VM, Lambert JS.

Sex Transm Infect. 2009 Apr;85(2):82-7. doi: 10.1136/sti.2008.032300. Epub 2008 Nov 5.


High prevalence of hypertension and placental insufficiency, but no in utero HIV transmission, among women on HAART with stillbirths in Botswana.

Shapiro RL, Souda S, Parekh N, Binda K, Kayembe M, Lockman S, Svab P, Babitseng O, Powis K, Jimbo W, Creek T, Makhema J, Essex M, Roberts DJ.

PLoS One. 2012;7(2):e31580. doi: 10.1371/journal.pone.0031580. Epub 2012 Feb 22.


Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland.

Townsend CL, Cortina-Borja M, Peckham CS, Tookey PA.

AIDS. 2007 May 11;21(8):1019-26.


Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women.

Grosch-Woerner I, Puch K, Maier RF, Niehues T, Notheis G, Patel D, Casteleyn S, Feiterna-Sperling C, Groeger S, Zaknun D; Multicenter Interdisciplinary Study Group Germany/Austria.

HIV Med. 2008 Jan;9(1):6-13. doi: 10.1111/j.1468-1293.2008.00520.x.


Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn.

Hernàndez S, Morén C, López M, Coll O, Cardellach F, Gratacós E, Miró O, Garrabou G.

AIDS. 2012 Feb 20;26(4):419-28. doi: 10.1097/QAD.0b013e32834f3232.


Pregnancy rates and birth outcomes among women on efavirenz-containing highly active antiretroviral therapy in Botswana.

Bussmann H, Wester CW, Wester CN, Lekoko B, Okezie O, Thomas AM, DeGruttola SM, Makhema J, Essex M, Marlink RG.

J Acquir Immune Defic Syndr. 2007 Jul 1;45(3):269-73.


Trends in birth weight and gestational age for infants born to HIV-infected, antiretroviral treatment-naive women in Malawi.

Taha TE, Dadabhai SS, Rahman MH, Sun J, Kumwenda J, Kumwenda NI.

Pediatr Infect Dis J. 2012 May;31(5):481-6. doi: 10.1097/INF.0b013e31824d9bd9.


Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy.

Haeri S, Shauer M, Dale M, Leslie J, Baker AM, Saddlemire S, Boggess K.

Am J Obstet Gynecol. 2009 Sep;201(3):315.e1-5. doi: 10.1016/j.ajog.2009.06.017.


Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana.

Powis KM, Smeaton L, Ogwu A, Lockman S, Dryden-Peterson S, van Widenfelt E, Leidner J, Makhema J, Essex M, Shapiro RL.

J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):131-8. doi: 10.1097/QAI.0b013e3181ffa4f5.


Combination antiretroviral use and preterm birth.

Watts DH, Williams PL, Kacanek D, Griner R, Rich K, Hazra R, Mofenson LM, Mendez HA; Pediatric HIV/AIDS Cohort Study.

J Infect Dis. 2013 Feb 15;207(4):612-21. doi: 10.1093/infdis/jis728. Epub 2012 Nov 29.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk